BMX — BioMaxima SA Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro CapContrarian
- PLN122.93m
- PLN109.24m
- PLN81.09m
- 88
- 76
- 37
- 78
Annual cashflow statement for BioMaxima SA, fiscal year end - December 31st, PLN millions except per share, conversion factor applied.
2017 December 31st | 2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | PAS | PAS | PAS | PAS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 0.806 | -0.482 | -0.014 | 7.36 | 12.8 |
| Depreciation | |||||
| Non-Cash Items | 0.001 | 0.05 | -0.101 | 0.16 | 0.023 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.767 | 1.15 | 3.36 | -5.44 | -14.6 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Net Change in Other Assets & Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 1.84 | 2.12 | 4.93 | 3.97 | -0.132 |
| Capital Expenditures | -2.17 | -17.4 | -1.64 | -1.88 | -4.48 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0.131 | 0.264 | 0.039 | 0.231 | 1.11 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -2.04 | -17.2 | -1.6 | -1.65 | -3.37 |
| Financing Cash Flow Items | -0.114 | 3.99 | 0.09 | 0.16 | -0.169 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0.39 | 14.8 | -3.85 | 1.48 | 2.11 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0.193 | -0.286 | -0.518 | 3.8 | -1.39 |